维生素D对血糖参数和阿迪波涅丁在妊娠糖尿病中的影响
Amna Nadeem1, Ayesha Sadiqa2, Muniza Saeed3
1Amna Nadeem, M.Phil. Department of Physiology, CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan. National University of Medical Sciences, Rawalpindi, Pakistan.
Pakistan journal of medical sciences
|September 16, 2024
概括
维生素D补充剂改善了孕期糖尿病妇女的血糖控制,显著降低了血糖,胰岛素和HOMA-IR. 然而,维生素D并没有显著影响HbA1c或阿迪波内克丁水平.
科学领域:
- 内分泌学 在内分泌学.
- 营养科学 营养科学
- 孕产妇健康 孕产妇健康
背景情况:
- 孕期糖尿病 (GDM) 是一种常见的妊娠并发症.
- 维生素D缺乏症在患有GDM的女性中很普遍.
- 在GDM中,最佳的血糖控制对母亲和胎儿的结果至关重要.
研究的目的:
- 研究维生素D补充剂对被诊断患有妊娠糖尿病的妇女关键血糖指标的影响.
- 为了评估维生素D治疗后血糖,胰岛素,HbA1c,HOMA-IR和子蛋白的变化.
主要方法:
- 进行了一项实验性研究,涉及34名患有GDM的维生素D缺乏妇女.
- 参与者被随机分配到对照组和接受200,000 IU维生素D剂量的病例组.
- 禁食血液样本在治疗前和治疗后被分析为各种生物化学标记物,使用光谱测量,过氧化酶方法和ELISA.
主要成果:
- 在治疗后的病例组中,维生素D补充导致血糖 (p=0.019),胰岛素 (p=0.001) 和HOMA-IR (p=0.001) 显著降低.
- 在治疗前或治疗后的组之间没有观察到HbA1c水平的显著差异 (p=0.169).
- 在补充剂后的病例组中,阿迪波涅克水平显示出非显著的增加 (p=0.194).
结论:
- 维生素D补充剂对改善妊娠糖尿病妇女的血糖控制具有显著的有益作用.
- 这项研究表明,维生素D补充剂在该人群中不会显著影响HbA1c或阿迪波内克水平.
- 进一步的研究可能会探索最佳的维生素D剂量及其对GDM管理的长期影响.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes
906
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
906
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
Glucagon-like Receptor Agonists
306
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
306
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K


